<?xml version="1.0" encoding="UTF-8"?>
<p id="para0045">Typically a synthetic viral peptide or a fusion recombinant peptide is delivered to the host via intramuscular or subcutaneous injection to provoke the immune response. The approach is relatively safe, offers the option of choosing the best desirable epitope as an antigen, and provokes a robust immune response, particularly when used in conjunction with adjuvants.</p>
